Amgen
The Clinical Sciences Director – Early Development, Oncology supports early phase clinical development by translating scientific and clinical strategy into actionable execution across clinical trials. This role provides hands-on oversight of protocol execution, medical data review, and clinical data quality to enable high-quality, decision-ready data. The position involves collaborating within cross-functional teams to ensure clinical trials are executed in alignment with protocol intent, regulatory expectations, and quality standards.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
39% below the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Clinical Scientist Director, Late Development Oncology- Thoracic/GI
lifelancer
Clinical Scientist Associate Director, Late Development Oncology
lifelancer
Associate Scientific Director, Oncology Early Development
AbbVie
Associate Scientific Director, Oncology Early Development
AbbVie
Clinical Scientist Associate Director, Cardiovascular
lifelancer
Senior Manager, Clinical Sciences
Regeneron Pharmaceuticals